Zacks Research Issues Negative Outlook for Pfizer Earnings
Pfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now forecasts that the biopharmaceutical company will earn $0.57 per share for the quarter, down from their previous […]
Pfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now forecasts that the biopharmaceutical company will earn $0.57 per share for the quarter, down from their previous […]
